吉林敖东涨2.09%，成交额8127.74万元，主力资金净流入111.83万元

Core Viewpoint - Jilin Aodong's stock price has shown significant growth this year, with a 23.47% increase, and the company is actively involved in various sectors including traditional Chinese medicine and health products [1][2]. Financial Performance - For the first half of 2025, Jilin Aodong reported a revenue of 1.126 billion yuan, a year-on-year decrease of 20.21%, while the net profit attributable to shareholders was 1.282 billion yuan, reflecting a year-on-year increase of 138.44% [2]. - Cumulative cash dividends since the company's A-share listing amount to 4.664 billion yuan, with 1.881 billion yuan distributed over the past three years [3]. Shareholder Information - As of June 30, 2025, the number of shareholders for Jilin Aodong was 66,000, a decrease of 1.60% from the previous period, with an average of 18,059 circulating shares per shareholder, an increase of 1.62% [2]. - The top ten circulating shareholders include Hong Kong Central Clearing Limited, which increased its holdings by 4.6149 million shares to 15.0138 million shares, and Southern CSI 500 ETF, which increased its holdings by 1.9148 million shares to 14.2479 million shares [3].